US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 1.270
  • +0.070+5.83%
Close Feb 14 16:00 ET
  • 1.270
  • 0.0000.00%
Post 18:59 ET
53.99MMarket Cap-0.64P/E (TTM)

About Repare Therapeutics Company

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

Company Profile

SymbolRPTX
Company NameRepare Therapeutics
Listing DateJun 19, 2020
Issue Price20.00
Founded2016
CEOMr. Lloyd M. Segal
MarketNASDAQ
Employees179
Fiscal Year Ends12-31
Address7171 Frederick-Banting,Suite 270
CitySaint-Laurent
ProvinceQuébec
CountryCanada
Zip CodeH4S 1Z9
Phone1-857-412-7018
Websitehttp://www.reparerx.com

Company Executives

  • Name
  • Position
  • Salary
  • Lloyd M. Segal
  • President, Chief Executive Officer and Director
  • 4.99M
  • Michael Zinda, PhD
  • Executive Vice President and Chief Scientific Officer
  • --
  • Steve Forte
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.93M
  • Dr. Maria Koehler, M.D.,PhD
  • Executive Vice President and Chief Medical Officer
  • 2.09M
  • Thomas Civik
  • Chairman of the Board
  • 291.49K
  • Dr. Steven H. Stein, M.D.
  • Director
  • --
  • Ann D. Rhoads
  • Independent Director
  • 274.74K
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 664.86K
  • Carol A. Schafer
  • Independent Director
  • 272.99K
  • Dr. Samarth Kulkarni, PhD
  • Independent Director
  • 265.31K
  • Dr. David P. Bonita, M.D.
  • Independent Director
  • 265.41K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025